JULIE CRAFT: Open Payments
NPI 1295402303 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,263 in 40 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $901 · 2025 $1,263
Food & beverage: $1,263
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 5 | $241 |
| UCB, Inc. | 3 | $152 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $138 |
| EMD Serono, Inc. | 4 | $123 |
| ABBVIE INC. | 5 | $109 |
| Alexion Pharmaceuticals, Inc. | 3 | $69 |
| GENZYME CORPORATION | 2 | $69 |
| SK Life Science, Inc. | 2 | $64 |
| Neurelis, Inc. | 3 | $58 |
| Celgene Corporation | 2 | $52 |
Products named: INGREZZA, Fintepla, HYQVIA, UBRELVY, VALTOCO, LEQEMBI, ZEPOSIA, KESIMPTA.
Industry payments across KS — which companies pay providers there.
